Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Loomba

Showing results (91-100 of 748) with videos related to

Pageof 75
Sort By:
Seminars in Liver Disease|February 13, 2016
Targeting Dysbiosis for the Treatment of Liver DiseaseGobind Anand, Amir Zarrinpar, Rohit Loomba
Current Opinion in Cardiology|February 25, 2025
Near infrared spectroscopy in the pediatric cardiac intensive care unit: accurately interpreting the dataIlias Iliopoulos, Saul Flores, Rohit Loomba
Nature Reviews. Endocrinology|November 24, 2021
Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLDNobuharu Tamaki, Veeral Ajmera, Rohit Loomba
Clinical and Molecular Hepatology|October 20, 2025
Erratum to 'Current burden of MASLD, MetALD, and hepatic fibrosis among US adults with prediabetes and diabetes, 2017-2023' [Clin Mol Hepatol 2025;31:e235-e238]Donghee Kim, Rohit Loomba, Aijaz Ahmed
Clinics in Liver Disease|April 6, 2023
Roles of Radiological Tests in Clinical Trials and the Clinical Management of Nonalcoholic Fatty Liver DiseaseWinston Dunn, Laurent Castera, Rohit Loomba
Alimentary Pharmacology & Therapeutics|May 7, 2021
Editorial: liver stiffness by magnetic resonance elastography and cardiovascular risk in non-alcoholic fatty liver disease-simply associated or more complicated? Authors' replyJung Gil Park, Jinho Jung, Rohit Loomba
Gut|May 9, 2020
Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challengesJean-François Dufour, Cyrielle Caussy, Rohit Loomba
Gastroenterology|January 21, 2019
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver DiseaseLaurent Castera, Mireen Friedrich-Rust, Rohit Loomba
Alimentary Pharmacology & Therapeutics|October 30, 2025
Research Communication: Real-World Clinical Experience With Seladelpar in Primary Biliary CholangitisSelena Z Kuo, Jeffrey Yin, Rohit Loomba
Gastroenterology|December 3, 2014
The TM6SF2 variants, novel genetic predictors for nonalcoholic steatohepatitisYoon-Seok Roh, Rohit Loomba, Ekihiro Seki
Pageof 75

Showing results (91-100 of 748) with videos related to

Sort By:
Pageof 75
Seminars in Liver Disease|February 13, 2016
Targeting Dysbiosis for the Treatment of Liver DiseaseGobind Anand, Amir Zarrinpar, Rohit Loomba
Current Opinion in Cardiology|February 25, 2025
Near infrared spectroscopy in the pediatric cardiac intensive care unit: accurately interpreting the dataIlias Iliopoulos, Saul Flores, Rohit Loomba
Nature Reviews. Endocrinology|November 24, 2021
Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLDNobuharu Tamaki, Veeral Ajmera, Rohit Loomba
Clinical and Molecular Hepatology|October 20, 2025
Erratum to 'Current burden of MASLD, MetALD, and hepatic fibrosis among US adults with prediabetes and diabetes, 2017-2023' [Clin Mol Hepatol 2025;31:e235-e238]Donghee Kim, Rohit Loomba, Aijaz Ahmed
Clinics in Liver Disease|April 6, 2023
Roles of Radiological Tests in Clinical Trials and the Clinical Management of Nonalcoholic Fatty Liver DiseaseWinston Dunn, Laurent Castera, Rohit Loomba
Alimentary Pharmacology & Therapeutics|May 7, 2021
Editorial: liver stiffness by magnetic resonance elastography and cardiovascular risk in non-alcoholic fatty liver disease-simply associated or more complicated? Authors' replyJung Gil Park, Jinho Jung, Rohit Loomba
Gut|May 9, 2020
Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challengesJean-François Dufour, Cyrielle Caussy, Rohit Loomba
Gastroenterology|January 21, 2019
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver DiseaseLaurent Castera, Mireen Friedrich-Rust, Rohit Loomba
Alimentary Pharmacology & Therapeutics|October 30, 2025
Research Communication: Real-World Clinical Experience With Seladelpar in Primary Biliary CholangitisSelena Z Kuo, Jeffrey Yin, Rohit Loomba
Gastroenterology|December 3, 2014
The TM6SF2 variants, novel genetic predictors for nonalcoholic steatohepatitisYoon-Seok Roh, Rohit Loomba, Ekihiro Seki
Pageof 75